mTORC2 activation is regulated by the urokinase receptor (uPAR) in bladder cancer

Andrew M. Hau, Mariah Z. Leivo, Andrew S. Gilder, Jing Jing Hu, Steven L. Gonias, Donna E. Hansel

Research output: Contribution to journalArticlepeer-review

13 Scopus citations


Mammalian target of rapamycin complex 2 (mTORC2) has been identified as a major regulator of bladder cancer cell migration and invasion. Upstream pathways that mediate mTORC2 activation remain poorly defined. Urokinase-type plasminogen activator receptor (uPAR) is a GPI-anchored membrane protein and known activator of cell-signaling. We identified increased uPAR expression in 94% of invasive human bladder cancers and in 54–71% of non-invasive bladder cancers, depending on grade. Normal urothelium was uPAR-immunonegative. Analysis of publicly available datasets identified uPAR gene amplification or mRNA upregulation in a subset of bladder cancer patients with reduced overall survival. Using biochemical approaches, we showed that uPAR activates mTORC2 in bladder cancer cells. Highly invasive bladder cancer cell lines, including T24, J82 and UM-UC-3 cells, showed increased uPAR mRNA expression and protein levels compared with the less aggressive cell lines, UROtsa and RT4. uPAR gene-silencing significantly reduced phosphorylation of Serine-473 in Akt, an mTORC2 target. uPAR gene-silencing also reduced bladder cancer cell migration and Matrigel invasion. S473 phosphorylation was observed by immunohistochemistry in human bladder cancers only when the tumors expressed high levels of uPAR. S473 phosphorylation was not controlled by uPAR in bladder cancer cell lines that are PTEN-negative; however, this result probably did not reflect altered mTORC2 regulation. Instead, PTEN deficiency de-repressed alternative kinases that phosphorylate S473. Our results suggest that uPAR and mTORC2 are components of a single cell-signaling pathway. Targeting uPAR or mTORC2 may be beneficial in patients with bladder cancer.

Original languageEnglish (US)
Pages (from-to)96-106
Number of pages11
JournalCellular Signalling
StatePublished - Jan 1 2017


  • Akt
  • Cell migration
  • Urokinase-type plasminogen activator
  • mTORC2
  • uPAR

ASJC Scopus subject areas

  • Cell Biology


Dive into the research topics of 'mTORC2 activation is regulated by the urokinase receptor (uPAR) in bladder cancer'. Together they form a unique fingerprint.

Cite this